170 related articles for article (PubMed ID: 8411447)
21. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.
Eiseman JL; Rogers FA; Guo Y; Kauffman J; Sentz DL; Klinger MF; Callery PS; Kyprianou N
Cancer Res; 1998 Nov; 58(21):4864-70. PubMed ID: 9809992
[TBL] [Abstract][Full Text] [Related]
22. Effect of suramin on human prostate cancer cells in vitro.
La Rocca RV; Danesi R; Cooper MR; Jamis-Dow CA; Ewing MW; Linehan WM; Myers CE
J Urol; 1991 Feb; 145(2):393-8. PubMed ID: 1824865
[TBL] [Abstract][Full Text] [Related]
23. Induction of programmed death/apoptosis androgen-dependent mouse mammary tumor cell line (Shionogi Carcinoma 115) by androgen withdrawal.
Furuya Y; Isaacs JT; Shimazaki J
Jpn J Cancer Res; 1995 Dec; 86(12):1159-65. PubMed ID: 8636004
[TBL] [Abstract][Full Text] [Related]
24. Apoptosis in androgen-independent mouse mammary tumor cells induced by 5-fluorodeoxyuridine but not by androgen withdrawal.
Furuya Y; Shimazaki J
Anticancer Res; 1996; 16(5A):2613-8. PubMed ID: 8917359
[TBL] [Abstract][Full Text] [Related]
25. [Potentiation of cytotoxicity of electromagnetic shock waves by suramin, "in vitro" study].
Rosell D; Robles JE; Aguera L; Abad JI; RodrÃguez-Rubio FI; Zudaire JJ; Berian JM
Actas Urol Esp; 1994 Jan; 18(1):29-33; discussion 34. PubMed ID: 8191943
[TBL] [Abstract][Full Text] [Related]
26. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
27. Combination adriamycin and suramin induces apoptosis in bcl-2 expressing prostate carcinoma cells.
Tu SM; McConnell K; Marin MC; Campbell ML; Fernandez A; von Eschenbach AC; McDonnell TJ
Cancer Lett; 1995 Jul; 93(2):147-55. PubMed ID: 7621422
[TBL] [Abstract][Full Text] [Related]
28. Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill.
Bromfield GP; Meng A; Warde P; Bristow RG
Prostate Cancer Prostatic Dis; 2003; 6(1):73-85. PubMed ID: 12664070
[TBL] [Abstract][Full Text] [Related]
29. Effect of suramin on the mitogenic response of the human prostate carcinoma cell line PC-3.
Ewing MW; Liu SC; Gnarra JR; Walther MM; Meyers CE; Linehan WM
Cancer; 1993 Feb; 71(3 Suppl):1151-8. PubMed ID: 8428338
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of prostatic tumor cell proliferation by suramin: alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distribution.
Kim JH; Sherwood ER; Sutkowski DM; Lee C; Kozlowski JM
J Urol; 1991 Jul; 146(1):171-6. PubMed ID: 2056586
[TBL] [Abstract][Full Text] [Related]
31. Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells.
Palayoor ST; Bump EA; Calderwood SK; Bartol S; Coleman CN
Clin Cancer Res; 1998 Mar; 4(3):763-71. PubMed ID: 9533546
[TBL] [Abstract][Full Text] [Related]
32. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
33. Caspase-1 enhances the apoptotic response of prostate cancer cells to ionizing radiation.
Winter RN; Rhee JG; Kyprianou N
Anticancer Res; 2004; 24(3a):1377-86. PubMed ID: 15274298
[TBL] [Abstract][Full Text] [Related]
34. Reversal by transferrin of growth-inhibitory effect of suramin on hormone-refractory human prostate cancer cells.
Donat SM; Powell CT; Israeli RS; Fair WR; Heston WD
J Natl Cancer Inst; 1995 Jan; 87(1):41-6. PubMed ID: 7666462
[TBL] [Abstract][Full Text] [Related]
35. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
Boylan M; van den Berg HW; Lynch M
Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
[TBL] [Abstract][Full Text] [Related]
36. Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate.
Samid D; Shack S; Myers CE
J Clin Invest; 1993 May; 91(5):2288-95. PubMed ID: 8486788
[TBL] [Abstract][Full Text] [Related]
37. Targeting apoptosis by hydroxymethylacylfulvene in combination with gamma radiation in prostate tumor cells.
Woynarowska BA; Roberts K; Woynarowski JM; MacDonald JR; Herman TS
Radiat Res; 2000 Oct; 154(4):429-38. PubMed ID: 11023607
[TBL] [Abstract][Full Text] [Related]
38. Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin.
Zellweger T; Miyake H; July LV; Akbari M; Kiyama S; Gleave ME
Neoplasia; 2001; 3(4):360-7. PubMed ID: 11571636
[TBL] [Abstract][Full Text] [Related]
39. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells.
Robertson CN; Roberson KM; Padilla GM; O'Brien ET; Cook JM; Kim CS; Fine RL
J Natl Cancer Inst; 1996 Jul; 88(13):908-17. PubMed ID: 8656443
[TBL] [Abstract][Full Text] [Related]
40. MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner.
Feng FY; Zhang Y; Kothari V; Evans JR; Jackson WC; Chen W; Johnson SB; Luczak C; Wang S; Hamstra DA
Neoplasia; 2016 Apr; 18(4):213-22. PubMed ID: 27108384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
